ELF-l53 is a cell line that has been established from a patient with a poorly differentiated acute myeloid leukemia associated with an acute myelofibrosis. A majority of cells had a blast morphology with the phenotype of a myeloid hematopoietic progenitor, ie, CD34+, CD33+, CD13+, HLA-DR+, but CD38-, and the remaining cells (5% t o 10%) expressed platel e t restricted proteins such as CD41, CD42, CD36, CD61, and von Willebrand factor; some of them were polyploid (up t o 32N) and exhibited demarcation membranes and a granules. No erythroid or other lineage-specific markers were detected. Proliferation of ELF-l53 cells was highly stimulated by interleukin-3 (IL-3) and granulocyte-macrophage colonystimulating factor and t o a lesser extent by stem cell factor and IL-6. In contrast, the cell line did not respond t o erythropoietin, leukemia inhibitory factor, IL-7, IL-11, granulocyte colony-stimulating factor, and basic fibroblast growth factor. ELF-l53 cells could be separated by flow cytometry into three discrete cell populations (CD34+/CD61-, CD34+/CD61+, and CD34-/CD61+) with different proliferative and endomi-ONTINUOUS HEMATOPOIETIC cell lines are useful tools to study regulation of gene expression during differentiation. In addition, several of them respond to growth factors and are now widely used to study the signal transduction of growth factors and their effects on the proliferation and differentiation.
ONTINUOUS HEMATOPOIETIC cell lines are useful tools to study regulation of gene expression during differentiation. In addition, several of them respond to growth factors and are now widely used to study the signal transduction of growth factors and their effects on the proliferation and differentiation.
Cell lines are especially interesting for the megakaryocytic lineage because its study has been hampered by the scarceness of megakaryocytes (MK) in the bone marrow. For this purpose, cell lines with an MK phenotype have been established and described both in the murine and human species.'"' Useful information has been obtained from their studies. However, the great majority of the human MK cell lines have an abnormal phenotype because they coexpress MK and erythroid-specific markers of differentiati~n.~,''"~ In addition, none of these cell lines represent a differentiation model that includes all the cellular stages from the MK progenitor to the mature MK. Indeed, the majority of the totality of the cells already express glycoprotein (GP) IIb/ IIIa and eventually other platelet protein^.^,^.^.'^.'^ Therefore, these cells have already turned on the terminal differentiation program of the MK lineage.
Expression of these MK markers are usually increased by phorbol ester treatment that, in contrast, switches off those of the erythroid
In this background, we report the growth and the differentiation of a recently established cell line called ELF-153. The cell line, although abnormal, represents a cellular model much closer to the normal differentiation than previously described human MK cell lines. ELF-l53 may be a useful model for investigating the molecular regulation of MKspecific genes.
C

MATERIALS AND METHODS
Cell line. ELF-l53 has been derived from a patient exhibiting an acute myelofibrosis in August 1986 that preceeded the manifestation of an acute leukemia in April 1987.I8.l9 The leukemia was cytochemically poorly differentiated with 5% Sudan-black-positive Blood, Vol 84, No 4 (August 15), 1994 pp 1085-1097 totic properties corresponding t o distinct stages of the mega karyocyte (MK) differentiation. This MK differentiation, which involved a minority of ELF-153, could be increased in the presence of 5-azacytidine and phorbol ester, but could not be significantly modified by growth factors. By contrast, cytochalasin B dramatically induced polyploidization without differentiation. It is noteworthy that association of 5-azacytidine t o cytochalasin B dramatically induced the production of polyploid MK cells. To understand the molecular mechanisms underlying this MK differentiation, the expression of GATA-1 and GATA-2 was investigated in subpopulations of ELF-153. A high level of GATA-1 and GATA-2 mRNA was only present in the CD61' cells. Therefore, these two transactivating factors may play an important role in the MK differentiation of ELF-153. We conclude that ELF-l53 might be an important tool t o investigate the mechanisms by which transcription factors control differentiation of MK progenitors.
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blasts. It was immunologically characterized by the expression of HLA-DR (38%), of myeloid markers (CD13', 70%; CD33'. 88%; CD34', 59%), and of glycophorin A (GPA; 31 %). CD42 was detectable, but on a variable percentage of cells (3% to 12%). The cell line established at Hannover Medical School (Hannover, Germany) in refractory relapse in February 1988 has been continuously cultivated in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF). Its karyotype [43, XY, , -14, -17, de1(5)(q13q31), t(12; 14)(p11.2;ql1.2)] is identical to that found in the patient at the time of diagnosis.
Cell culture. ELF-l53 cells were cultured in a medium supplemented with 10% fetal calf serum (FCS; Eurobio, Paris, France), usually in the presence of GM-CSF (2.5 ng/mL; Genetics Institute, Cambridge, MA). They were incubated at 37°C in a 100% humidified incubator with 5% COz. 12-0-Tetradecanoylphorbol-13-acetate (TPA), 5-azacytidine, and cytochalasin B (Sigma, St Louis, MO) were used at 1 nmoVL, 5 pmoUL, and 5 prnoVL, respectively.
['I+thymidine incorporation. ELF-l53 cells were cultured for 24 hours in a serum-free a medium containing deionized bovine serum albumin (150 pg/mL; Cohn fraction V; Sigma) and transfemn (300 pg/mL; Sigma) in the absence of growth factors. Cells were then seeded in 96-well microplates at a concentration of 1. of growth factors. The following human recombinant growth factors were used: GM-CSF (0.025 to 2.5 ng/mL), granulocyte-CSF (G-CSF; 100 ng/mL; Amgen, Thousand Oaks, CA), interleukin-3 (IL-3; 100 IU/mL; Genetics Institute), IL-6 (100 IU/mL; Genetics Institute), IL-7 (100 IUlmL; Immunex, Seattle, WA), IL-l 1 (100 ng/mL; Genetics Institute), erythropoietin (Epo; 1 IU/mL; Amersham, Les Ulis, France), leukemia inhibiting factor (LIF; 100 IU/mL, Immunex), stem cell factor (SCF; 50 and 500 ng/mL; Amgen), and basic fibroblast growth factor (bFGF; 100 ng/mL; Genzyme, Cambridge, MA). After 48 hours of culture, 0.15 pCi of [jH]-T (48 Ci/ mmol; Amersham) was added in each well for 6 hours. Cells were harvested onto glass filters. Radioactivity was determined by liquid scintillation counting after TCA precipitation.
Semisolid culture. Methylcellulose cultures were performed as previously described.2" Cells (5 X IO3) were seeded in a volume of 1 mL containing 45% methylcellulose supplemented with 10% FCS. Several human recombinant growth factors (described above) were added. After 10 days of culture, colonies (clusters of 10 cells or more) were counted under an inverted microscope, Typically, colonies contained 10 to 500 cells when ELF-l53 cells were cultured in the presence of GM-CSF (2.5 ng/mL).
In addition, cells ( 5 X IO') were cultured by the plasma clot technique as previously described2' using 2.5 ng/mL GM-CSF. ELF-153 colonies were directly analyzed in situ after an indirect immunofluorescent labeling with an anti-GPIIIa monoclonal antibody Flow cytometry. Analysis was performed on a FACSort (Becton Dickinson) or on an ATC 3000 flow cytometer (Odam-Bruker, Wissenburg, France) equipped with two argon ion lasers (Innova, 70-4 and 90-5; Coherent, Palo Alto, CA) tuned to deliver 400 mW, respectively, at 488 nm and 360 nm. A morphologic gate was set using the wide-angle light scatter and the forward-angle light scatter for the FACSort or the volume measured with an electrical impedance particule counter incorporated in the ATC 3000. Negative controls for setting the FITC gate were irrelevant mouse Igs that corresponded to the same isotype as the studied MoAb. For the phenotypic studies, the percentage of FITC-positive cells was determined after analysis of 10,000 cells for each antibody. In the FITCRIoechst experiments, the DNA content of CD61 + and CD41 cells was determined after analysis of 20,000 cells in the FITC gate. In the CD34-PE/CD61-FITC cell sorting experiments, three gates based on the FITC/PE fluorescences were defined (see Fig 6) : CD34+/CD61-(MoAb; Y2-51). (gate no. 3), CD34+/CD61' (gate no. 2), and CD34-/CD61' (gate no. 1). Cells were sterily sorted at a flow rate of 1,500 cells/s. The purity of these sorted cell populations exceeded 90% after examination by fluorescence microscopy of deflected droplets. In the threecolor experiment, the DNA content was analyzed in these three previous gates. In one experiment, the CD61 cells (the 50% more negative) were sorted and seeded at a concentration of 4 X l@ cells in 2 mL of a medium. They were cultured for 4 days in the absence or the presence of different growth factors (2.5 ng/mL of GM-CSF, 50 ng/mL of SCF, 100 Ul/mL of E-6, and a mixture of these three factors). After this culture, cells were subsequently relabeled with the Y2/5 1 MoAb and analyzed by flow cytometry for the presence of CD61.
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Immunomagnetic bead separation. ELF-153 cells were incubated with an anti-CD61 MoAb (Y2/51 or C17) and washed twice. Immunomagnetic beads were added for 30 minutes with a 1 5 target cell to bead ratio (Dynabeads "450; Dynal, Oslo, Norway). CD61' cells were isolated using a magnetic particule concentrator with a For personal use only. on October 23, 2017. by guest www.bloodjournal.org From recovery of about 2%. After May-Griinwald-Giemsa staining. some CD61 ' were large cells with polylobulated nuclei. whereas CD61 cells had a blast morphology but still contained some CD41" and vWF-expressing cells. These cells were further cultured for 3 hours before RNA isolation.
RNA i s o k t r i o~l m d Northern blot. Total RNAs were isolated by a previously described technique." Total RNAs ( I O p g ) were run on I % agarose/6% formaldehyde denaturing gel in migration buffer (20 mmol/L MOPS, I mmol/L EDTA. 8.5 mmol/L sodium acetate, pH 7) and transfered onto filter (Hybond C-xtra: Amersham). Radioactive probes were synthetised using multiprime DNA labeling kit (Amersham) and SO pCi of ["PlrrdCTP (>3,00OCi/mmol: Dupont de Nemours. Les Ulis. France). Filters were hybridized overnight at 42°C with radioactive probes, washed in 0 . 1 X SSC, 0.1% sodium dodecyl sulfate (SDS) for 30 minutes at 55°C. and autoradiographed for 12 hours to 7 days at -80°C. Films were scanned and the RNA amount per lane was normalized with the results obtained with the 28s probe."
Llltrcl.stnrctrtrcd morpholoXy. Cultured cells were fixed in 2.5% glutaraldehyde for I hour. washed and postfixed in l % osmium tetroxyde, dehydrated, and embedded in epon.
Ultrathin sections were examined with a Philips CM 10 electron microscope (Phillips, Eindoven. The Netherlands) after uranyl acetate and lead citrate staining.
Detection ofplatclct p e r o . d m e . Cells were fixed using 1.25% glutaraldehyde in Gey's buffer for 10 minutes." washed, and incubated in a diaminobenzidine medium." Cells were then postfixed using osmium tetroxide. dehydrated, and embedded in epon. Unfixed cells were also incubated in diaminobenzidine medium according to the method of Roels et al.25 After several washes, the cells were fixed by 1.25%-glutaraldehyde and then processed for standard electron microscopy.
Immto~ogold lohelirlg of plareler GPIIh/IlIu. Unfixed cells (IO') were incubated for I hour at 4°C with either a polyclonal antibody to GPllbllIla'" or the Y2/S1 MoAb. After three washes in Trisbuffer. cells were incubated for I hour at 4°C with either 200 pL of goat antirabbit IgG coupled to S nm gold particles or goat antimouse IgG coupled to I O nm gold particles. Cells were then fixed and processed for standard electron microscopy.
RESULTS
Morphologic urd ultrnstructurnl aspect of ELF-153 cells.
May-Griinwald-Giemsa staining of ELF-l 53 cells showed the existence of two morphologically distinct populations.
The majority (SS%) was of small size and looked like marrow blast cells. The remaining cells had the appearance of mature MK as indicated by their large size and multilobulated nuclei.
At the ultrastructural level, the majority of cells had a blast morphology with a large nucleolus (Fig I) ; a minority of them were big in size (between 30 to 46 pm) and had eight centrioles. These giant cells possessed a lobulated nucleus. Some of them exhibited demarcation membranes or membrane complexes that were also present in a few smaller cells (Figs 2 and 3) . Platelet peroxidase was rarely detected in large cells. No evidence for an erythroid or granulo-monocytoid component was observed. Phenotype ojELF-153 cells. Most ELF-l 53 cells (95%) exhibited immature markers of the "myeloid" lineages such as CD13, CD33, and CD34 as determined by fluorescent microscopy and flow cytometry (Table 1) . HLA-DR was present in about 70% of cells, whereas CD38 was absent. Specific granulocytic, monocytic, and lymphoid (T and B) antigens (CD2, CDllb, CDllc, CD14, CD15, CD19, and CD20) were not detected, except for the CD4 and CD10 antigens, which were faintly expressed in 80% and less than 5% of ELF-l53 cells, respectively. Erythroid-lineage antigens (GPA and CA I) that are usually detected in human MK cell lines were undetectable in ELF-153 cells. Consistent with this result, hemoglobin was not shown by the benzidine coloration in ELF-l53 cells cultured with GM-CSF, with Epo, or after hemin stimulation (data not shown).
The presence of platelet antigens was subsequently investigated. Among nonrestricted platelet antigens, the CD9, CD3 1, CD51 (vitronectin receptor a chain), CD63, and CD107a (LAMP-l) were present on more than 90% of ELF-153 cells. In contrast, CD36, a late antigen of the MK differentiation but also expressed during erythroid and monocytic differentiation, was present on l % of ELF-l53 cells. Among more restricted proteins, vWF was found with a granular fluorescent pattern in 5% to 10% of ELF-l53 cells. Platelet GPIIIa (CD61) and platelet GPIIb (CD41) were detected by fluorescent microscopy on 2% to 5% and 2% to 3% of ELF-I53 cells, respectively. Nonetheless, low expressions of CD41 and CD61 were detected by flow cytometry on 15% and 20%, respectively. Platelet GPIba (CD42b) and GPlX (CD42a) were present on a very small number of ELF-l53 cells (about 1%).
At the ultrastructural level, a minority of small and large cells showed a weak labeling for GPIIb/IIIa and few cells had a strong labeling. The development of demarcation membranes, membrane complexes, and a-granules occurred both in labeled and apparently unlabeled cells. In fact, blasts frequently exhibited numerous short pseudopods at one pole that at a higher magnification coincided with the GPIIb/IIIa staining (Fig l) . Several coated pits were also labeled for GPIIb/IIIa, suggesting that they were fusing with the cell membrane because the MoAb was applied on living cells. In unlabeled blasts, a strong accumulation of coated vesicules were present at the cell periphery in a zone without ribosomes (Fig 1C) .
A majority of cells exhibiting some demarcation membranes appeared negative for GPITb/IIIa on a section at ultrastructural level (Fig 2) . However, because labeling was often located at one pole of the cells (Fig l) , this result does not exclude that these cells express GPIIb/IIIa. Some giant cells with demarcation membranes were weakly labeled for GPIIb/IIIa (Fig 2) . In addition, some small cells (6 pm) that exhibited numerous blebs and a round small nucleus but no specific MK organelles exhibited a membrane labeling for GPIIbnIIa.
The more mature cells, either large or small, exhibited an intense membrane GPIIbnIIa labeling, large blebs, devel-1091 opped demarcation membranes, and numerous a-granules (Fig 3) .
Effect of growth factors on ELF-l53 proliferation. ELF-153 cells can survive or grow slowly in the absence of any added growth factor. Nevertheless, the cell line was usually cultured in the presence of GM-CSF because its growth was increased (doubling time, 36 hours). Then, the effects of several growth factors on the proliferation of ELF-l53 cells were studied by measuring the ['HI-T incorporation into DNA (Fig 4) . GM-CSF stimulated the [3H]-T incorporation in a concentration-dependent manner with the maximal stimulation (2.2-fold basal incorporation) at 0.25 ng/mL. IL-3 (100 U/mL) and aplastic sera (10%) both stimulated to the same extent the t3H]-T incorporation in ELF-l53 cells (about twofold). IL-6 (100 U/mL) and SCF (50 ng/mL) increased ['HI-T incorporation by about 1.25-fold the basal level. SCF and GM-SCF (0.25 to 2.5 ng/mL) or SCF and IL-3 (100 U/ mL) had additional, but no synergistic effects on ['HI-T incorporation. Epo (2 U/mL), IL-7 (100 U/mL), LIF (100 U/mL), bFGF (100 ng/mL), IL-l1 (100 ng/mL), and G-CSF (10 ng/mL) had no significant effect on [3H]-T incorporation in ELF-l53 cells (less than 1.1-fold).
Similar results were obtained when proliferation was determined by clonogenic assay. Both GM-CSF and IL-3 increased 10-fold the cloning efficiency in comparison to unstimulated cultures, whereas IL-6 and SCF had mild effects (twofold increase) and Epo had no effect.
According to these results, GM-CSF receptor (GM-CSF-R), c-kit (SCF receptor), IL-6 receptor (IL-6-R), and gp130 were detected, by flow cytometry, on all ELF-l53 cells, whereas the Epo receptor was undetectable (Table 1) .
Ploidy analysis.
We next analyzed whether ELF-l53 cells could undergo polyploidization. A minority (about 4%) of ELF-l53 cells were polyploid in the presence of GM-CSF. Double labeling between CD61 (or CD41) and DNA staining showed that the majority of polyploid cells have MK features (CD61' or CD41+) and, among these MK cells, about 20% were polyploid (Fig 5) . As well as for normal megakaryocytes, the ploidy was correlated with the volume of ELF-l53 cells (Fig 6) .
Induction of MK terminal differentiation by cytokines and chemical agents. The effects of growth factors and chemical agents on the MK differentiation of ELF-l53 cells were determined by CD34, CD4 1, and CD6 1 expression studies, ploidy analysis, and ultrastructural observations. Compared with a GM-CSF stimulation, IL-6 or SCF did not significantly modify the CD34 expression. Nevertheless, the percentage of cells that was highly stained by the anti-CD41 (CD41++) or anti-CD61 (CD61++) MoAbs was increased 1.5-and 2-fold by IL-6, and 2-and 2.5-fold by SCF. By contrast, the percentage of polyploid cells was weakly decreased in the presence of IL-6 or SCF (l % to 2% v 4%). At the ultrastructural level, no main differences were observed in the MK maturation of the cell line regardless of the cytokine or the combination of cytokines used (GM-CSF, IL-3, IL-11, SCF, and LIF).
TPA enhanced the MK phenotype increasing CD41 and CD61 expression, but weakly (Fig 5) , and decreasing CD34 expression (data not shown). In addition, TPA increased the number of 4N cells and, to a lesser extent, the upper ploidy classes (Fig 5) . Induction with 5-azacytidine, a DNA methylation inhibitor, also increased the percentage of CD41++ and CD61++ cells (at least sixfold), whereas the percentage of CD34+ cells was decreased (Fig 5) . Moreover, this treatment did not stimulate GPA expression in ELF-l53 cells (data not shown). Although the number of polyploid cells was faintly increased in the presence of 5-azacytidine, the ploidy of CD61 + + cells was unmodified (Fig 5) . By contrast, cytochalasin B, an actin polymerization inhibitor, increased dramatically the ploidy of ELF-l53 cells, whereas the antigen expressions were unmodified (Fig 5) . Therefore, we tested whether 5-azacytidine acts synergistically with cytochalasin B. Association of these two agents increased dramatically the production of polyploid CD61++ cells (Fig 5) . Ultrastructural studies confirmed these results. Indeed, the number of mature MK cells was increased in the presence of 5-azacytidine. In addition, the combination of 5-azacytidine with cytochalasin B provoked the appearance of numerous cells with a polylobulated nucleus; part of them had immature nucleus and were devoid of cytoplasmic maturation (data not shown).
Analysis of ELF-l53 subpopulations. To demonstrate that the CD61+ cells derive from the differentiation of a compartment of immature cells, we used four different approaches.
Firstly, ELF-l53 cells were cloned in methyl cellulose medium. Colonies (150) derived from these cultures were pipetted-off and amplified; only five clones were obtained. All of them were phenotypically identical to the parental cell line, ie, 95% of immature cells and 5% of MK cells.
Secondly, ELF-l53 colony formation was studied in plasma clot using an in situ immunolabeling technique. At 5 days of culture, ELF-l53 cells gave rise to small colonies (4 to 10 cells) of two types. The first one contained cells that had a large size and that were labeled by the anti-CD61 MoAb. A second type of colony, about one-third, was devoid of CD61+ cells. At day 9, the first type of colony was almost totally lysed, whereas the second type has grown and contained 20 to 50 cells (1 to 4 cells per colony were CD61+).
Thirdly, CD61-cells were sorted by flow cytometry and
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were cultured in the presence of growth factors. After 4 days of culture, CD61+ cells were detected again with a similar percentage as in the unseparated population in the presence of GM-CSF and to a lesser extent with L -6 and SCF. The maximal induction was obtained with the addition of all three growth factors. Fourthly, we characterized more precisely the different cellular populations of ELF-l53 cell line by simultaneously analyzing CD34 and CD61 expressions. According to the CD34-PE versus CD61-FITC cytogram, we defined three subpopulations of ELF-l53 cells, ie, CD34+/CD61-cells (95%), CD34+/CD61+ (2.5%), and CD34-/CD61+ (2.5%) (Fig 6) . The clonogenic properties of these sorted subpopulations were determined in semisolid medium in the presence of GM-CSF, IL-3, or IL-6. CD34+/CD61-cells gave rise to colonies in presence of IL-3 or GM-CSF, but only to a few colonies with IL-6 ( Table 2 ). CD34+/CD61+ and CD34-/ CD61+ cells had both very low clonogenic properties with GM-CSF and IL-3 and none with IL-6. The ploidy distribution of these three cell subpopulations was subsequently studied by a three-color technique. CD34+/CD61-cells had a ploidy close to the global ELF-l53 cell population ( Fig  6) . The CD34+/CD61+ population contained about 40% of polyploid cells and the modal ploidy class was 4N (40%); 8% of these cells had a ploidy of 32N. In contrast, ploidy of the CD34-/CD61+ population was lower, with most of them being 2N (50%) and about 15% polyploid. In addition, the S-phase of this cell fraction was profoundly decreased.
Gene expression. To demonstrate that ELF-l53 cell line might be an interesting model for investigations of megakaryocytopoiesis, we studied the expression of several genes reflecting the differentiation properties of ELF-153.
Firstly, we checked that ELF-l53 cells did not express specific erythroid genes. Neither globin chains ( E and y) nor GPA mRNA were detected by Northern blot in ELF-l53 cells cultured in the presence of GM-CSF (Fig 7) or after hemin stimulation (data not shown).
Secondly, we investigated whether the differences of MK antigen expression in the ELF-l53 cells was correlated with a modification at the level of their RNAs. The immunomagnetic bead technique with an anti-CD61 MoAb allowed us to obtain a purified CD61 + population, whereas the CD61 -population was contaminated with some CD41' cells (data not shown). GPIIb (CD41) mRNA was still present in CD61 -cells as expected, because of the relative inefficiency of the immunomagnetic bead separation. We used a 28s rRNA probe to evaluate the amount of total RNA because the actin expression is increased during the MK differentiation. The level of GPIIb mRNA was increased in CD61+ cells about 10-fold in comparison to parental ELF-l53 cells (Fig 7) . Finally, expression of the GATA family genes that are known to be implicated in gene transactivation during hematopoietic differentiation was studied. GATA-I and GATA-2 mRNAs were expressed in parental ELF-IS3 cells at a lower level than in HEL cells. Interestingly, their expressions were increased at least by IO-fold in the CD61' cells (Fig  7) . In contrast. the level of GATA-I and GATA-2 was profoundly decreased in CD61 ~ cells. Reverse transcriptasepolymerase chain reaction experiments for tal-l, GATA-3. and efs-l were performed as previously described.*' All these mRNA were expressed in parental ELF-IS3 cells, but at a much lower rate than in HEL cells (data not shown). suggesting that these mRNA are expressed in a few ELF-IS3 cells.
DISCUSSION
In this report, we have studied the growth and differentiation of the ELF-IS3 cell line that appears to be an interesting model for MK differentiation studies. This cell line has the advantage of being quite different from the previous human cell lines because it corresponds to earlier stages of the MK differentiation. Indeed, the great majority of ELF-IS3 cells only expressed antigens associated with hematopoietic progenitors. ie. CD34, HLA-DR, CD33, or CD13. These antigens are present on colony-forming unit (CFU)-granulocyte, erythrocyte, monocyte, megakaryocyte, burst-forming uniterythroid, and CFU-granulocyte-macrophage. CD34 and HLA-DR are also present on CFU-MK,'X,''' but it is still unknown whether CD33 and CD13 are expressed on MK progenitors. Nevertheless, CD33 expression by megakaryo-MOUTHON ET AL blasts has been described."' Interestingly, the CD38 antigen present on all classes of hematopoietic progenitors and absent from primitive progenitors'' was not expressed by ELF-IS3 cells. Recent results from our laboratory show that CD38 is absent or faintly expressed in a large fraction of M K progenitors.7' Nonspecific platelet proteins such a s CD3 1. CD63, CD107a (LAMP-l), and CDI07b (LAMP-2) are also present on a majority of ELF-IS3 cells. In contrast. a minority of cells exhibit restricted platelet proteins such as CD41. CD42, CD61. CD36, CD62. and vWF. which are mainly expressed during M K terminal differentiation.""' In parallel with these phenotypic changes, platelet organelles such as demarcation membranes and cu-granules were present in a majority of these M K cells and polyploid cells (up to 32N) are observed.
In fact, ELF-l S3 seems to represent an M K differentiation model with a continuum of cells that mimics in part the normal differentiation. except that the compartment of immature cells is much higher than the mature one. This assumption is confirmed by the following data.
( l ) Labeling with CD61 and CD41 MoAbs was quite heterogenous. A larger fraction (up to 20% for CD61 ) was labeled very weakly and a minority of ELF-I S3 cells (about 2%) was strongly stained (2 Log greater than the previous one) and corresponds to the more mature cells. Moreover. later markers of differentiation. such a s CD42 and CD36. were present on very rare cells (about I%).
( 2 ) ELF-IS3 cells could be separated into three cell sub- In ELF-153. we could not detect GPA and globin chains at mRNA or protein level and no specific markers of other cell lineages could be found except CD4. However, the CD4 may be present on the MK lineage" as well as on some hematopoietic progenitors.jN It remains that we cannot totally exclude the hypothesis that ELF-IS3 is a pluripotent cell line because its phenotype corresponds to an hematopoietic progenitor. It is possible that ELF-IS3 cells may not be able to direct them toward another differentiation program in our culture conditions. ( 3 )
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At the ultrastructural level, ELF-l53 maturing cells exhibit both demarcation membranes and a-granules. In most other MK cell lines, even after phorbol ester treatment, cells may exhibit demarcation membranes but in the absence or the presence at low level of a -g r a n u l e~. '~?~~ These differences between ELF-l53 and the other MK cell lines were further ascertained when studying the expression of GATA proteins. GATA-l is a transcriptional factor restricted to the erythroid, MK, and mastocyhc lineage^.^'^^^ In the MK lineage, GATA-1 is necessary to obtain a high expression of CD41.4' GATA-l mRNA and proteins were barely detected in total ELF-l53 cells, whereas their expression were greatly increased in purified CD61+ cells. This result suggests that ELF-l53 terminal differentiation is related to this upregulation of GATA-1. A similar finding was observed for GATA-2. The biological role of GATA-2 in the MK differentiation is presently unknown.40 Therefore, for the future, ELF-l53 may be a powerful model in which to precisely understand the role of these transcription factors as well as early molecular events involved in the MK differentiation. This approach can be performed by gene transfer of these transcription factor cDNAs into ELF-l53 cells as done in the murine 416B cell line.44, 45 In contrast, such an approach would be quite difficult in the other human MK cell lines, such as Meg 01 or HEL, because these transcription factors are constitutively expressed at a high ELF-153 cells that survive or proliferate slowly in the absence of added growth factor respond in proliferation to some growth factors in a similar but not identical way as late MK progenitors. Indeed, ELF-l53 cells respond to IL-3, GM-CSF, and to a lesser extent, SCF and IL-6. As for late MK no synergistic effect between these growth factors is found on ELF-l53 cells. Other growth factors such as LIF, IL-l1 and Epo, which also regulate the MK differentiati~n,~~.~~ did not stimulate ELF-l53 proliferation.
None of these factors could really increase the MK maturation of ELF-l53 cell line. In contrast, during normal MK differentiation, IL-6 may favor polyploidization and cytoplasmic mat~ration.~'.~' Several cell lines with an MK phenotype such as UT-7 and M07-E are dependent on growth factors for their survival and proliferation,6." but induction of a MK differentiation has only been described after TPA treat men^^.^^ TPA also induces the MK differentiation of ELF-l53 cells but to a low extent. Indeed, expression of GPIIb-GPIIIa was enhanced simultaneously with an increase in the 4N cells. However, this ploidy increase may be only caused by the blockage of cells at the G2/M, as observed in several cell lines.52.S3
Treatment with 5-azacytidine specifically increases MK antigen expression in ELF-l53 cells, as recently reported in the 416B cell line. 45 In this latest report, it is closely related to an increase in GATA-l mRNA expression. However, 5-azacytidine did not stimulate the endoreduplication of MK cells. By contrast, cytochalasin B provoked a dramatical polyploidization of ELF-l53 cells, as recently obtained on normal MK,54 whereas MK marker expression was unmodified. Cytochalasin B blocks cytokinesis by inhibiting actin polyrnerizati~n,'~ raising the idea that the lack of cytokinesis is directly involved in endomitosis. These data showed that, in ELF-l53 cells, MK antigen expression (regulated by GATA genes) may occur independently of the endoreduplication process (lack of cytokinesis) and that both these mecanisms cooperate in the production of polyploid MK. This hypothesis is consistent with the dissociation of maturation and endoreduplication observed during o n t~g e n e s i s~~ or during in vitro MK differentiati~n.~'
In conclusion, the ELF-l53 cell line appears as a cellular model that may greatly facilitate investigations of early phases of the MK differentiation, especially the molecular events that induce expression of MK-specific genes. Such an approach can be performed in the future by transferring transactivating factors or cytokine receptor genes in these cells.
